|
We had honor to accept at our Cell Therapy Clinic of National Medical University and Embryonic Tissues Center “EmCell” Mr. G.C. on January 23-27, 1998. This is second visit of Mr. G.C. to the Cell Therapy clinic. After first one (December 12-14, 1996) Mr. G.C. experienced long term effects (substantial increasing of physical and mental work capacity, sexual activity, cosmetic changes).
We have established the following diagnosis: Aging. Male climax.
Tests:
24.01.98. Average blood count:
Erythrocytes 4.6*1012/l, Hb 152 g/l, color index 1.0, thrombocytes 210*109/l, leukocytes 4.2*109/l, stab neutrophils 2%, segmented neutrophils 64%, eosinophiles 6%, lymphocytes 21%, monocytes 7%, ESR 2 mm/hr.
25.01.98. Average blood count:
Erythrocytes 4.5*1012/l, Hb 154 g/l, color index 1.0, thrombocytes 210*109/l, leukocytes 5.6*109/l, stab neutrophils 2%, segmented neutrophils 60%, eosinophiles 6%, lymphocytes 32%, monocytes 3%, ESR 3 mm/hr.
26.01.98. Chemistry:
Bilirubin total 17.1 mmol/l, direct neg., indirect 17.1 mmol/l, ALT 0.40 mmol/l, ACT 0.20 mmol/l, thymol test 2.7 units, beta-lipoproteins 0.566.
26.01.98. Urine analysis:
Volume 40 ml, transparent, light-yellow, protein neg., sugar neg., flat epithelium in small quantity, leukocytes 1-2 in the visual field, oxalates in small quantity.
26.01.98. ECG:
Regular sinus rhythm. Sinus bradycardia. Heart rate 66 bpm.
Mr. G.C. received a course of Cell Therapy.
24.01.98. Transplantation of the sample 3038P179 (human embryonic cell suspensions of regenerative, rejuvenating, antiatherosclerotic and vascular action), intravenously dropwise, in the volume of 2.6 ml.
26.01.98. Transplantation of the sample 3038P83 (human embryonic cell suspensions of immunocorrecting action), intravenously dropwise, in the volume of 2.2 ml.
The cell suspension samples 3038P179 and 3038P83 possessed the functional activity as mentioned above and are certified as follows:
| Bacterial sterility test |
Negative |
| Prenatal diagnostic |
| Test with cardiolipid antigen |
Negative |
| Anti - HIV1/HIV2 |
Negative |
| HBsAg |
Negative |
| Fetal diagnostic |
| Enzygnost Anti - HIV1/HIV2 |
Negative |
| HBsAg monoclonal |
Negative |
| Anti - HBc monoclonal |
Negative |
| Anti - CMV/IgG+IgM |
Negative |
| Anti - Rubella Virus/IgG |
Negative |
| Varicella/Zoster |
Negative |
| Toxoplasmosis/IgG |
Negative |
The treatment was tolerated well. After Cell Therapy, syndrome of early posttransplantation amelioration in a form of increasing of mental working capacity, improving of mood, feeling of strength increase was observed. Significant improvement of vision was reported.
Mr. G.C. is recommended:
- to control testosterone level once per two months starting from April 1998,
- blood count once per three months, consultation at the Cell Therapy clinic by telephone or fax each 2-3 months,
- repeat the course of the Cell Therapy next autumn-winter.
Head of the Cell Therapy Clinic
of National Medical University and Embryonic Tissues Center "EmCell"
professor Alexander Smikodoub
January 27, 1998.
|
